Objective: The overall goal of this project was to examine the interactions of hyperglycemia and loss of ovarian hormones on the artery wall in a type I diabetic mouse model. Methods and Results: Intact or ovariectomized (ovariectomy; OVX) female BALB/C mice were fed a highcholesterol diet. Half the animals were treated with steptozotocin to induce insulin-deficient diabetes mellitus (D), generating 4 treatment groups: control, intact (CI); control, ovariectomized (COVX); diabetic, intact (DI); diabetic, ovariectomized (DOVX). We examined arterial structure and function and found: 1) Diabetes and ovariectomy additively increased endothelial layer permeability. 2) Arterial stiffening was increased in the diabetic and ovariectomy groups (DOVX). 3) Ovariectomy and diabetes (DOVX) synergistically increased atheroma formation. 4) Ultrastructural evaluation revealed that the basal lamina was often multilayered and formed convoluted aggregates separating endothelium from the internal elastic lamina in diabetic, but not control arteries or arteries from ovariectomized mice. Endothelium overlying these regions formed thin cytoplasmic extensions between these aggregates and was often separated from the basal lamina by electron lucent spaces. Conclusions: Our studies showed that diabetes and loss of ovarian function have additive and synergistic effects to worsen arterial pathophysiology by disrupting the arterial endothelial layer with increased permeability and increased atheroma formation.
INTRODUCTION
Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality in the United States and type 1 and type 2 diabetes mellitus are major risk factors for disease development. Type 1 diabetes mellitus (DM1) is associated with vascular stiffening (1) , increased LDL accumulation in the artery wall (12, 23, 30, 32, 41) , and atherosclerotic lesion development (2, 8) . In DM1 many factors may contribute to the deleterious changes occurring in the artery wall including generation of advanced glycation and lipoxidation end-products, upregulation of the receptor for advanced glycation endoproducts, increased oxidative stress, etc. (4, 7, 13, 24, 26) While microvascular permeability is clearly increased in DM1 (37, 46) , the effects of hyperglycemia on large artery permeability are less clear.
Endogenous estrogens are widely regarded as atheroprotective and loss of female sex hormones has been strongly associated with the development of atherosclerotic cardiovascular disease(39). Recent randomized clinical trials have generated skepticism regarding hormone replacement therapy's atheroprotective potential (19, 21, 29, 39) , however, clear and powerful protective effects of estrogen on atherosclerosis development have been demonstrated in many animal models and in observational human studies (5, 16, 20) . Previous work from this laboratory has demonstrated that 17-estradiol reduces arterial endothelial layer permeability and arterial LDL accumulation during an oxidant stress (42, 43) , attenuates arterial stiffening (28) , and decreases glycoxidative damage to the arterial wall in euglycemic animals (28, 42) . The effect of female sex hormones in the setting of diabetes mellitus is much less well defined. A previous study in male apolipoprotein E-mutant mice treated with streptozotocin (STZ) developed significantly more lesions in some (but not all) parts of the aorta and its main branches. Chronic treatment with 17 -estradiol lead to a significant decrease in blood glucose and triglyceride levels and reduced the lesion area in all vascular segments studied. (38) Page 3 of 27 Although much of the advantage of female gender in atherosclerotic cardiovascular disease is eliminated by diabetes, female sex hormones may still be playing a significant role in protection against vascular injury in diabetic women. The combination of DM1 and loss of female sex hormones has been postulated to be synergistic in its effect on artery pathophysiology, although the mechanism(s) for this synergistic effect are not known with certainty.
The overall goal of this project was to investigate the interactions of hyperglycemia and loss of ovarian function on arterial pathophysiology. Our studies were designed to examine artery permeability and LDL accumulation, arterial stiffening, endothelial layer ultrastructural changes, and atherosclerotic lesion development. We hypothesized that hyperglycemia-induced changes in these parameters would be potentiated by the loss of female sex hormones. We showed that at least one of the mechanisms for increased arterial pathophysiology in this setting was disruption of the arterial endothelial layer with increased permeability and increased atheroma formation.
MATERIALS AND METHODS

Chemicals and materials
Krebs'-Heinseleit buffer consisted of (in mM): NaCl 116, KCl 5, CaCl 2 *H20 2.4, MgCl 2 1.2, NH 2 PO4 1.2 and glucose 111. Bovine serum albumin (BSA) and dextran (65,000 MW fluorescently labeled with tetramethylrhodamine isothiocyanate, TRITC) were obtained from Sigma Chemical Company (St. Louis, MO).
Animal care and treatment
Ten-week old ovariectomized and intact BALB/c mice were obtained from Charles River Laboratories (Boston, MA) and housed in an approved facility. All protocols used in this study were approved by Animal Use and Care Committees (University of California, Davis) and conformed to guidelines set by the American Physiological Society and Animal Welfare Act.
Animals were kept on a 12 hr light-dark cycle and had access to food and water ad libitum. All Page 4 of 27 mice were placed on a high fat diet (Purina 15% butter, 1.25% cholesterol, 0.5% cholate) upon arrival and continued on the diet throughout treatment. At twelve weeks of age, mild hyperglycemia was induced in a subset of animals by intraperitoneal injection of streptozotocin (40 mg/kg) for 5 consecutive days (22) . Control mice were given saline as a vehicle control. To monitor blood glucose levels, approximately 100 ul of blood was taken from the saphenous vein of each animal every four weeks throughout the study. Injections were repeated at 7 weeks to maintain the hyperglycemic state and mice were sacrificed following 12 weeks of treatment.
Treatment groups for all experiments were as follows: control intact (CI), control ovariectomized (COVX), diabetic intact (DI), and diabetic and ovariectomized (DOVX). 
Preparation of fluorescently labeled LDL
Perfusion experiments
Mice were anesthetized with nembutal (50 mg/kg) and carotid arteries were isolated and removed for perfusion experiments as described previously (44) . Briefly, the carotid artery was isolated and both ends of the vessel were cannulated, with the distal cannula placed just proximal to the bifurcation of the internal and external carotid. The artery then was removed, placed into a perfusion chamber and bathed in oxygenated Krebs-Henseleit buffer (pH 7.4, 37 ºC).
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Measurement of arterial LDL accumulation and measurement of arterial permeability
Quantitative fluorescence microscopy for measurement of lipoprotein flux in mouse carotid arteries has previously been described in detail (44) . Arterial permeability was estimated by the rate of accumulation of 65,000 MW dextran labeled with tetramethylrhodamine isothiocyanate (TRITC-dextran). TRITC-dextran was diluted to a final concentration of ~ 95 ug/ml in KrebsHeinseleit buffer containing 1% w/v BSA. All perfusion experiment protocols are identical to those described for measurement of arterial LDL accumulation. Dextran accumulation was used as an index of arterial permeability because dextran is a nonlipid reference molecule that does not specifically bind to the arterial matrix.
Plasma assays
Following removal of the carotid arteries, blood was collected from each animal through the right ventricle using a 23-guage needle and heparinized syringe. Blood was transferred to vacutainers and centrifuged at 2800 rpm for 10 min. at 4 ºC. Plasma was separated and stored at -20 ºC until analysis. Plasma glucose was measured using an Analox Instruments GM7
analyzer. Plasma lipid levels were determined by IDEXX Veterinary Services (Sacramento, CA).
Tissue assays
Immediately after exsanguination, the aorta and uterus were removed, rinsed in KrebsHeinseleit buffer and stored at -80 ºC until use. The aorta was used for atheroma quantification and analysis of vascular stiffening. The uterus was dried, weighed and used as a functional index of female sex hormone status. Following arterial compliance measurements, the remaining aorta was dried and weighed. This tissue was used for determination of total protein (modified Lowry assay) and total collagen (Woessner assay).
Assessment of vascular stiffening
Maximum Passive Stiffness. Maximum passive stiffness (MPS) of mouse thoracic aortic rings was determine through load-strain analysis ex vivo (6, 36) . The vessels were hydrated Page 6 of 27 overnight in Krebs' buffer at 2°C. Two stainless steel rods were inserted through the lumen of a 1 mm thoracic aortic segment in a parallel fashion while the vessel was immersed in Krebs' buffer. One rod was attached to a motorized controller, while the other to a force transducer (FT10; Grass Instruments, Quincy, MA). As the motorized controller pulled the rods apart, the vessel tension was recorded. In preparation for each stretch, the aortic segments were conditioned three times to a standard strain (10% of maximal strain) that was determined in previous experiments. The vessel was stretched until breakage. Load vs. strain curves were generated for each vessel. MPS is defined as the maximal slope of the load vs. strain relationship.
Quantitative and qualitative analysis of atheroma
Aortas were characterized for qualitative assessment of lesion morphology and quantification of atheroma (40). Briefly, after careful removal of periadventitial fat, aortas were fixed (4% followed by 10% paraformaldehyde overnight), and cut into three segments: proximal segment including all of the aortic arch; mid segment consisting of the thoracic and suprarenal aorta; and distal segment consisting of the infrarenal aorta proximal to the iliac bifurcation. Aortic ± SEM) determined for each atheroma by morphometric analysis with a computer-assisted imaging system (Image Pro Plus, version 4.1). We've previously determined the quantification data to be highly reproducible having an intra-observer error of < 6%. To assess for possible regional differences in atheroma development with the various experimental treatments, we determined lesion area as a function of location in the aorta (proximal, mid, or distal segment).
Atheroma distribution was expressed as percent of lesions per segment. Qualitative morphologic assessment of lesion complexity was performed with light microscopy for the following parameters: absence or presence of foam cells, wall thickness, vessel wall architecture integrity, nuclear proliferation and luminal extension. Lesion morphology, complexity, and severity were used to classify the stage of lesions.
Electron microscopy
Isolated carotid arteries and aortas were perfused with oxygenated, supplemented cell culture medium to rinse away blood and were subsequently fixed with 10% formalin for 10 min. The vessels were then stored in 10% formalin until embedding at the Electron Microscopy Laboratory, Department of Pathology and Laboratory Medicine, School of Veterinary Medicine, University of California at Davis. In brief, the tissues were secondarily fixed with 1% OsO 4 in 0.1M PO 4 buffer for 60 min. After rinsing in DDH 2 O, the vessels were placed in 0.1% tannic acid for 30 min and subsequently treated after rinsing in DDH 2 O with 1% uranyl acetate in DDH 2 O for 90 min. The tissues then were dehydrated through graded acetone. Finally, the vessels were embedded in an epoxy resin mixture with a cross-section orientation. Ultra-thin sections were cut with a diamond knife and picked up on copper grids. They were stained with uranyl acetate and lead citrate before viewing on a Phillips CM120 Biotwin (Hillsboro, OR).
Micrographs were taken with a Gatan MegaScan, model 794/20, digital camera (Pleasanton, CA). The aortas and carotids from three animals per treatment group were analyzed and representative pictures were chosen for each group.
Statistical analyses
All statistical analyses utilized SigmaStat 2.0 software by Jandel Scientific. Mean and standard error of the mean were determined for each treatment group. Treatment groups were compared using one-way ANOVA. Student-Newman-Keuls post hoc test was used to analyze for significant effects (p = 0.05). Data were analyzed by the Kruskal-Wallis ANOVA on ranks.
Dunn's post hoc test was used to analyze for significant effects (95 percent confidence limits).
RESULTS
Plasma glucose and lipoprotein levels
Streptozotocin injected mice experienced 3-4 fold increase in plasma glucose levels over saline injected-animals that was maintained throughout the treatment period. Glucose values 4 weeks after intiation of the study were: CI 100 ± 5 mg/dl, COVX 110 ± 5 mg/dl, DI 415 ± 20 mg/dl, and DOVX 380 ± 80 mg/dl. These values were not significantly changed at 8 and 12 weeks after treatment. Ovariectomy had no effect on plasma glucose levels in diabetic animals. While glucose levels were elevated slightly by ovariectomy in control animals, this increase was not statistically significant. Both DI and DOVX animals had significantly higher plasma glucose levels than CI or COVX animals at 4, 8, and 12 weeks. There were no significant differences in plasma glucose concentration between the DI and DOVX groups or the CI and COVX groups.
Total cholesterol, triglycerides, and HDL were determined for 6 animals per group. Results of these measurements in summarized in table 1. DI had significantly greater total cholesterol than CI and COVX. DOVX also was significantly greater than CI. Triglycerides were not significantly different. HDL in DI were significantly greater than in CI.
Estradiol values for non-diabetic control (CI) and intact diabetic (DI) animals were similar, 38.05 ± 0.25 pg/ml and 38.14 ± 0.48 pg/ml (mean ± SEM), respectively. Ovariectomy significantly reduced estradiol levels in control ovariectomized animals (COVX; 8.4 ± 0.44 pg/ml; 78.1% reduction) and in diabetic ovariectomized animals (DOVX; 11 ± 0.4 pg/ml; 71% reduction). N = 5 mice in each group. Estradiol levels were not significantly different between COVX and DOVX mice, but were significantly different (p<0.05) from intact control animals.
Body and uterine weights
Body dry weights were CI 21.3 ± 0.9 g, COVX 24.0 ± 0.4 g, DI 17.5 ± 0.9 g, and DOVX 19.5 ± 1.0 g. DI body dry weights were significantly less than CI and COVX. DOVX weights were significantly less than COVX. Uterine dry weights were CI 0.0595 ± 0.009 g, COVX 0.0108 ± 0.001 g, DI 0.0085 ± 0.002 g, DOVX 0.0041 ± 0.0009 g. COVX animals demonstrated a significant 81% decrease in uterine weight relative to CI animals. DI uterine weights were also significantly less than CI. Uterine weights for diabetic animals (DI and DOVX) were significantly lower than control groups; however, DOVX still experienced a 56% reduction in uterine weight relative to DI, as expected due to the ovariectomy.
Effect of hyperglycemia and ovariectomy on arterial endothelial layer permeability
Using quantitative fluorescence microscopy, we measured the rate of accumulation of 65,000 MW TRITC-dextran in individually perfused carotid arteries. Dextran accumulation rate was used as an index of arterial permeability. Accumulation rates for the four treatment groups were 
Effect of ovariectomy and diabetes on arterial LDL accumulation
Following vascular permeability measurements, DiI-LDL accumulation rates were determined for the same arteries. Arterial LDL accumulation rates were as follows: CI 1.281 ± 0.106, COVX 
Atheroma development
We analyzed aortas from each of the four study groups (n = 10 aortas per group) by qualitative morphology and quantification of atheroma. The atherogenic diet in the presence or absence of hyperglycemia resulted in aortic lesions after 12 weeks, a time frame consistent with previously published reports for atherosclerosis susceptible mouse strains (31) . However, no atheromatous lesions developed in CI or COVX mice. Early atherosclerotic lesions were present in the intimal layer of aortas of only the two diabetic groups after 3 months of cholesterol feeding; DOVX and DI. In these mice, atheromatous lesions were distinguished by lipid infiltration into the subendothelium of the vessel wall and the presence of fatty streaks, but not raised intimal lesions. In DOVX mice, lesions were more advanced with larger deposits of intracellular fat and foam cells, but were not complicated lesions. Compared to DI mice, atherosclerotic lesions in DOVX mice were more advanced and larger, but did not have cellular architecture disruption, cellular disarray, or proliferation of nuclei in the intima. Representative lesions of CI, DI, and DOVX mouse aortic segments are shown in Figure 3 .
We also characterized atheroma by size and location in the aorta (proximal, mid, and distal segments) using quantitative morphometry. Mean lesion area and distribution of atheroma in aortic segments of DOVX, DI, COVX, and CI mice (n = 30 segments per aorta) are shown in Figure 5 . After the 3 month study period, DOVX mice had 21.6-fold greater total mean lesion area than DI mice (p<0.01). Interestingly, the mid thoracic aorta was the primary lesion predilection site for atheroma formation in DOVX mice (65.4% of atheroma), with only 19.5% of atheroma in the proximal segment and 15.1% in the distal segment. In these mice, the mid aorta displayed greater lipid deposition, larger lesions, and more lesions than other segments. In contrast, in DI mice atheroma were significantly smaller and confined to the proximal segment only. There were no atheromas in the distal aortas of DOVX or DI mice.
Electron microscopy of the arterial intima
The overall ultrastructural organization of both carotid and aorta samples from all groups was similar. The endothelium overlaid a contiguous elastic lamina. The media consisted of 3 Intercellular junctions between endothelial cells were formed in regions of cytoplasmic overlap and were characterized by closely opposed cell membranes containing fine densities (Fig. 5.A.) and segmental tight junctional complexes (Fig. 5.B.) . These structures were intact in all groups.
Control and ovariectomized mice had only slight undulations of the cell at its basal attachment to the underlying basal lamina. The basal lamina consisted of thin sheets of finely granular material arranged in one or two distinct layers that were consistently closely opposed to the endothelial cell membrane.
Ultrastructural changes in streptozotocin-treated mice were limited to the endothelium and underlying basal lamina. Similar changes were seen in samples from both aorta and carotid arteries. In these groups, the basal lamina was often multilayered and formed convoluted aggregates separating endothelium from the internal elastic lamina (Fig. 5.C.) . Endothelium overlying these regions formed thin cytoplasmic extensions between these aggregates and was often separated from the basal lamina by electron lucent spaces (Fig. 5.C.) . In rare instances, endothelial cells were partially dissociated from the basal lamina leaving clear spaces (Fig 6.D.) .
No difference between intact and ovariectomized mice was evident in the nature or extent of these changes.
DISCUSSION
Increased arterial permeability is one mechanism that appears to be important in early atherogenesis in this new mouse model. This is consistent with previous studies in animal models and in human patients that have shown increased microvascular permeability with type 1 diabetes (3, 11, 25, 45) . Previous work from this laboratory and others have shown that estrogen withdrawal increased and estrogen treatment reduced endothelial layer permeability (9, 10, 14, 15, 18, 27, 28, 35, 47) . Thus, these studies predicted that diabetes and loss of ovarian estrogens would act to increase endothelial layer permeability and provide a mechanism for the devastating vascular effects of diabetes and loss of ovarian hormones on the arterial wall.
Indeed this was supported by the current experiments. However, other studies investigating the effects of diabetes or estrogen on vascular permeability have failed to find this relationship (17, 34) . These differing findings may be due to length of treatment, use of different models, or differences in other experimental conditions. LDL accumulation in the artery wall was not statistically different in any of the groups although there appeared to be a trend towards increased LDL accumulation in the diabetic groups. LDL accumulation in the artery wall is a complex process involving endothelial layer permeability, binding to glycosaminoglycans, cells, and other lipoproteins, and efflux of the LDL from the artery wall. The studies that we have conducted suggest that in diabetics the mechanisms for early atherogenesis are more strongly dependent changes in endothelial layer permeability than binding to artery wall components or reduction of LDL efflux.
Independently, both diabetes mellitus and estrogen withdrawl have been shown to increase artery stiffening. No studies of this type have ever been attempted in mouse models of diabetes or estrogen status. Our studies show that in combination these 2 factors act additively to increase arterial stiffening. Further studies are needed to determine mechanisms for this pathophysiological effect.
Our data showed what can be most closely related to fatty streaks in this new animal model. These fatty streaks were primarily distributed in the proximal and thoracic aorta of diabetic mice and more commonly covered greater surface area in the diabetic, ovariectomized mice. These studies highlight the synergistic effect of diabetes and loss of ovarian hormones on arterial pathobiology. Our studies also suggest that the mechanism for greater atheroma formation at this stage of atheroma development is related to increased arterial permeability rather than LDL binding.
The arterial ultrastructural studies showed significant changes only in diabetic animals. No ultrastructural changes were identified when control and ovariectomized arteries were imaged. SEM) for atheroma in proximal, mid, and distal aortic segments of DOVX, DI, COVX, and CI mice (n=30 segments/aorta and 10 aortas/study group) after 12 weeks of cholesterol feeding.
The bar denotes statistically significant (p<0.01) differences between groups. 
